Therapeutic medications against diabetes: What we have and what we expect
Author:
Funder
Research and Development
Shanghai Shen Kang Hospital Development Center
National Natural Science Foundation of China
Shanghai Health System
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference179 articles.
1. IDF Diabetes Atlas;International Diabetes Federation,2017
2. Comparison of demographic factors and cardiovascular risk factor control among U.S. adults with type 2 diabetes by insulin treatment classification;Wong;J. Diabetes Complicat.,2012
3. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients;Ji;Am. J. Med.,2013
4. Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study;Bala;Pol. Arch. Med. Wewn.,2011
5. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database: a series of retrospective analyses of data from 1998 through 2002;Fox;Clin. Ther.,2006
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pulmonary administration of cross-linked chitosan nanoparticles of genistein for regulating blood glucose;International Journal of Biological Macromolecules;2024-09
2. Observational study on stability of within-day glycemic variability of type 2 diabetes inpatients treated with decoctions of traditional Chinese medicine;Frontiers in Pharmacology;2024-07-19
3. Phytomedicine approach for management of diabetes mellitus: an overview of scientifically confirmed medicinal plants with hypoglycaemic properties and their probable mechanism of action;Phytochemistry Reviews;2024-06-22
4. Neuropharmacological Insights into Type 3 Diabetes: Molecular Mechanisms, Therapeutic Advances, and Future Directions;J BIOL REG HOMEOS AG;2024
5. Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications;Frontiers in Endocrinology;2024-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3